- Ana Sayfa
- Uygulama Analitiği
- Biosimilar
- Biosimilar Vs. DRUGDOCS
Biosimilar vs DRUGDOCS Kullanım & İstatistikleri
Biologic drugs offer important treatment options for patients suffering from auto-immune disorders such as rheumatoid arthritis and for common cancers including breast and colon. Biosimilar and interchangeable products, which can loosely be thought of as ‘generic’ biologics, are important for promoting competition and driving down costs. The FDA maintains a list of approved biosimilars in the Purple Book. The Biosimilar iOS app provides a handy reference to the Purple Book as well as important information related to prescribing and dispensing for clinicians and pharmacists navigating this complex area of drug therapeutics.
** Disclaimer ** - non-medical users should ask for a doctor’s advice in addition to using this app and before making any medical decisions.
- Apple App Store
- Ücretliler
- Medikal
Mağaza Sıralaması
- -
DRUGDOCS® provides health professionals with current, evidence-based information on the drugs they prescribe with direct access to publications.
- Apple App Store
- BOŞTA
- Medikal
Mağaza Sıralaması
- -
Biosimilar ile DRUGDOCS için sıralama karşılaştırması
Son 28 gündeki Biosimilar sıralama trendini DRUGDOCSile karşılaştırın
Biosimilar#132
Rank
Biosimilar vs. DRUGDOCS ülke karşılaştırmasına göre sıralama
Son 28 gündeki Biosimilar sıralama trendini DRUGDOCSile karşılaştırın
Tüm kategoriler
Mevcut veri yok
Medikal
Ücretsiz deneme sürümümüzü kullanarak istediğiniz siteyle karşılaştırın
Biosimilar VS.
DRUGDOCS
Aralık 19, 2024